Skip to main content

Day: August 15, 2024

Peyto Exploration & Development Corp. Confirms Monthly Dividend for September 13, 2024

CALGARY, Alberta, Aug. 15, 2024 (GLOBE NEWSWIRE) — Peyto Exploration & Development Corp. (TSX: PEY) (“Peyto”) confirms that the monthly dividend with respect to August 2024 of $0.11 per common share is to be paid on September 13, 2024, for shareholders of record on August 31, 2024. Dividends paid by Peyto to Canadian residents are eligible dividends for Canadian income tax purposes. Shareholders and interested investors are encouraged to visit the Peyto website at www.peyto.com to learn more about what makes Peyto one of North America’s most exciting energy companies. The website also includes a monthly report, which discusses various topics chosen by the President and CEO and includes estimates of monthly capital expenditures and production. For further information please contact: Jean-Paul LachancePresident and...

Continue reading

Rezolve AI Limited Closes Business Combination with Armada Acquisition Corp. I; Announces Date for Commencement of Trading on the Nasdaq; Launching one of the first pure play Ai companies with its own foundation Large Language Model – brainpowa

Rezolve’s proprietary LLM – brainpowa- is customized and focuses on commerce and retail enabling ‘conversational commerce’ and instant checkout in 95 languages Rezolve AI ordinary shares and warrants to begin trading on the Nasdaq on August 16, 2024 under the ticker symbols “RZLV” and “RZLVW”, respectively Rezolve AI is advancing digital retail engagement for merchants with its proprietary technology by providing customers with a Gen AI powered sales engine designed to significantly improve search, advice and revenue generationLONDON and PHILADELPHIA, Aug. 15, 2024 (GLOBE NEWSWIRE) — Rezolve AI Limited, (“Rezolve” or the “Company”), a leading provider of AI-driven engagement platforms for retail and commerce, today announced that it has completed its business...

Continue reading

Orkuveitan – Green Bond Auction August 22nd

Reykjavík Energy (Orkuveita Reykjavíkur) is holding a bond auction on Tuesday, June 11th, 2024. Bonds in the green bond classes OR020934 GB and OR180255 GB as well as a new green bond class OR280845 GB will be offered for sale. OR020934 GB bears fixed indexed interest and pays equal payments every six months with a final maturity date of September 2nd, 2034. Previously, bonds with a nominal value of ISK 27,607 million have been issued in the class. OR0280845 GB bears fixed indexed interest and pays equal payments every six months with a final maturity date of August 28th, 2045. The bond carries 3.70% fixed interest and is redeemable after 13 years. OR0180255 GB bears fixed indexed interest and pays equal payments every six months with a final maturity date of February 18th, 2055. Previously, bonds with a nominal value of ISK 34,246 million...

Continue reading

Aecon Announces TSX Approval of Normal Course Issuer Bid

TORONTO, Aug. 15, 2024 (GLOBE NEWSWIRE) — Aecon Group Inc. (TSX: ARE) (“Aecon”) announced today receipt of regulatory approval from the Toronto Stock Exchange (the “TSX”) of its notice of intention to make a normal course issuer bid (the “NCIB”). Under the NCIB, Aecon may purchase for cancellation, during the period commencing on August 19, 2024 and ending on the earlier of August 18, 2025 and the date on which Aecon reaches the maximum purchases permitted under the NCIB, up to 3,126,306 common shares of Aecon (“Common Shares”), representing 5% of the issued and outstanding Common Shares. Aecon had a total of 62,526,130 issued and outstanding Common Shares as of August 7, 2024. Purchases of Common Shares under the NCIB will be made in accordance with TSX rules through the facilities of the TSX and/or through alternative Canadian...

Continue reading

TOFUTTI ANNOUNCES UNAUDITED RESULTS FOR THE THIRTEEN AND TWENTY-SIX WEEKS ENDED JUNE 29, 2024

Cranford, New Jersey, Aug. 15, 2024 (GLOBE NEWSWIRE) — TOFUTTI BRANDS INC. (OTCQX Symbol: TOFB) today announced its results for thirteen and twenty-six weeks ended June 29, 2024. Tofutti Brands reported that net sales for the thirteen weeks ended June 29, 2024 decreased by $436,000, or 16%, to $2,283,000, from net sales of $2,719,000 for the thirteen weeks ended July 1, 2023. Sales of our vegan cheese products decreased to $1,926,000 for the thirteen weeks ended June 29, 2024 from $2,283,000 for the thirteen weeks ended July 1 2023. Sales of our frozen dessert products decreased to $357,000 in the thirteen weeks ended June 29, 2024 from $436,000 for the thirteen weeks ended July 1, 2026. For the twenty-six week period ended June 29, 2024, sales decreased by $713,000 or 14% to $4,495,000 compared to $5,208,000 for the twenty-six...

Continue reading

NI Holdings, Inc. Announces Leadership Change

FARGO, N.D., Aug. 15, 2024 (GLOBE NEWSWIRE) — NI Holdings, Inc. (NASDAQ: NODK) today announced that Michael J. Alexander has stepped down from his role as President and Chief Executive Officer of NI Holdings, along with his role as a board member of the company, effective August 13, 2024. To ensure seamless stewardship of the company until a permanent successor is named, the Board has appointed Cindy L. Launer as Interim Chief Executive Officer, effective August 13, 2024. Ms. Launer has served as an independent non-executive director on NI Holdings’ board since November 2019 and brings 18 years of experience in the insurance industry with a proven track record of success as a global finance and operations executive. Most recently, Ms. Launer served as Chief Operating Officer of AIG’s Commercial Insurance Business, before retiring...

Continue reading

Genius Group Announces Reverse Stock Split Effective on August 16, 2024

SINGAPORE, Aug. 15, 2024 (GLOBE NEWSWIRE) — Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered education group, today announced a 1-for-10 reverse stock split effective August 16, 2024, consolidating every 10 shares into 1 share. The Company’s common stock will trade on a post-split basis under the same symbol ‘GNS’ on NYSE American. The primary goal of the reverse stock split is to increase the per share market price of the Company’s ordinary shares to meet the minimum per share price requirement for continued listing on the NYSE. Shares of the Company’s common stock will be assigned a new CUSIP number (Y3005A117) and are expected to begin trading on a split-adjusted basis on Friday, August 16, 2024. The reverse stock split was approved by the Company’s...

Continue reading

Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of 2024

Record Total Revenues of $236 million for the first six months of 2024, an over ten-fold increase compared to same period in 2023Product revenues for the first six months were $66 million, a 190% increase from the same period last year, with Q2 product revenues contributing $53 millionLicense and other revenues for the first six months increased to $170 million, with Q2 license and other revenues contributing $145 millionAdjusted EBITDA in the first six months was $64 million, compared to negative ($147) million for the same period last year, with Q2 adjusted EBITDA contributing $102 millionAchieved numerous development and performance milestones including the recent filing acceptance of EU marketing application for AVT06, biosimilar candidate to Eylea® (aflibercept)Alvotech will conduct a business update conference call...

Continue reading

Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of 2024

Record Total Revenues of $236 million for the first six months of 2024, an over ten-fold increase compared to same period in 2023 Product revenues for the first six months were $66 million, a 190% increase from the same period last year, with Q2 product revenues contributing $53 million License and other revenues for the first six months increased to $170 million, with Q2 license and other revenues contributing $145 million Adjusted EBITDA in the first six months was $64 million, compared to negative ($147) million for the same period last year, with Q2 adjusted EBITDA contributing $102 million Achieved numerous development and performance milestones including the recent filing acceptance of EU marketing application for AVT06, biosimilar candidate to Eylea® (aflibercept) Alvotech will conduct a business update conference call and live...

Continue reading

Exela Technologies, Inc. Reports Second Quarter 2024 Results

Second Quarter HighlightsRevenue of $245.7 million, down 10.0% year-over-year Gross margin of 23.5%, up 120 bps year-over-year Interest expense of $23.1 million, down 48.7% year-over-year SG&A of $41.8 million, up 30.5% year-over-year Operating loss of $2.4 million, vs $11.2 million operating profit, year-over-year Net loss of $26.9 million ($25.7 million attributable to Exela Technologies, Inc.), an improvement of $4.0 million year-over-year Adjusted EBITDA of $13.7 million, down 39.0% year-over-yearIRVING, Texas, Aug. 15, 2024 (GLOBE NEWSWIRE) — Exela Technologies, Inc. (“Exela” or the “Company”) (NASDAQ: XELA, XELAP), a global business process automation (“BPA”) leader, announced today its financial results for the quarter ended June 30, 2024. “Our increased operating leverage and continued focus on cost management...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.